GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Board Meeting to Consider Q1 FY27 Un-Audited Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 05 Aug 2026, 05:01 PM IST  ·  BSE ID: fddfd3c0-fb0c-4d33-9943-5db137a9f549
View Original BSE Filing (PDF)
💡
In Simple Terms
Bafna Pharmaceuticals' board will meet on August 11, 2026, to review its financial results for April-June 2026.
🤖 AI Summary
  • Board of Directors meeting scheduled for August 11, 2026, to approve Un-Audited Financial Results.
  • Results to be considered are for the Quarter ended June 30, 2026.
  • Trading Window for Designated Persons closed from July 01, 2026, to August 13, 2026.
  • Closure is for the purpose of considering the Un-Audited Financial Results of the company.
  • Meeting convened under Regulation 29 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this board meeting intimation.
👤
Who Is Affected
Shareholders are not directly affected by this intimation, as it concerns a future board decision and compliance. Designated persons are restricted from trading.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the board meeting and implementing a trading window closure for insider trading prevention.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Outcome of Board Meeting on August 11, 2026 — check for Q1 FY27 financial results.
Release of Un-Audited Financial Results for Quarter ended June 30, 2026.
Review of detailed financial statements following board approval.
LOW RISK This filing is a standard regulatory update; it does not introduce new risks.
💡 Investor Takeaway
Bafna Pharmaceuticals Ltd's Board meeting on August 11, 2026, will consider Un-Audited Financial Results for Quarter ended June 30, 2026. The trading window for designated persons is closed from July 01, 2026, to August 13, 2026.
❓ Frequently Asked Questions
When is Bafna Pharmaceuticals' Board Meeting scheduled?
Bafna Pharmaceuticals' Board of Directors meeting is scheduled for Tuesday, August 11, 2026.
What is the purpose of the Board Meeting on August 11, 2026?
The meeting is scheduled to consider and approve the Un-Audited Financial Results of the Company for the Quarter ended June 30, 2026.
What is the period for which the trading window is closed for Bafna Pharmaceuticals?
The trading window for designated persons and their immediate relatives is closed from July 01, 2026, to August 13, 2026 (both days inclusive).
Under which regulation is this Board Meeting intimated?
The intimation of the Board Meeting is made pursuant to Regulation 29 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.